Agilent Technologies this week launched its SureSelect Kinome Target Enrichment Kit. The kit enables researchers to focus their next-generation sequencing studies on expressed kinases, the firm said.
Agilent's new assay was developed with Rene Bernards of the Netherlands Cancer Institute and targets genes for greater than 500 known kinases plus a number of cancer genes and untranslated regions. Customers can use Agilent's eArray xD tool to design custom kits.
Agilent said it has created protocols for using its new kit with sequencing instruments sold by Illumina and Life Technologies. Its SureSelect products are generally available in solution for larger studies and on arrays for smaller projects.